These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65. Plasmacytoid (CD68+CD123+) monocytes may play a crucial role in the pathogenesis of hydroa vacciniforme: a case report. Varughese N; Petrella T; Singer M; Carlson JA Am J Dermatopathol; 2009 Dec; 31(8):828-33. PubMed ID: 19730083 [TBL] [Abstract][Full Text] [Related]
66. Epstein-Barr virus: dermatologic associations and implications: part I. Mucocutaneous manifestations of Epstein-Barr virus and nonmalignant disorders. Hall LD; Eminger LA; Hesterman KS; Heymann WR J Am Acad Dermatol; 2015 Jan; 72(1):1-19; quiz 19-20. PubMed ID: 25497917 [TBL] [Abstract][Full Text] [Related]
67. Risk of mortality in hydroa vacciniforme and hypersensitivity to mosquito bites. Poligone B Br J Dermatol; 2015 Jan; 172(1):5-6. PubMed ID: 25581582 [No Abstract] [Full Text] [Related]
68. Hydroa vacciniforme-like lymphoproliferative disorder: a retrospective cohort study of seven pediatric cases. Ren F; Zhu J; Perry DM; Pruitt L; Elston DM Int J Dermatol; 2020 Aug; 59(8):e290-e292. PubMed ID: 32403170 [No Abstract] [Full Text] [Related]
69. Fatal natural killer cell lymphoma arising in a patient with a crop of Epstein-Barr virus-associated disorders. Nitta Y; Iwatsuki K; Kimura H; Kojima S; Morishima T; Tsuji K; Oono T Eur J Dermatol; 2005; 15(6):503-6. PubMed ID: 16280311 [TBL] [Abstract][Full Text] [Related]
70. [Hypersensitivity to mosquito bites and hydroa vacciniforme]. Iwatsuki K; Yamamoto T; Tsuji K Nihon Rinsho; 2006 Mar; 64 Suppl 3():657-61. PubMed ID: 16615554 [No Abstract] [Full Text] [Related]
71. Primary cutaneous extranodal natural killer/T-cell lymphoma presenting as bilateral erythematous patches on the arms. Moon IJ; Kang HJ; Lee MW; Lee WJ Indian J Dermatol Venereol Leprol; 2017; 83(4):453-456. PubMed ID: 28474639 [TBL] [Abstract][Full Text] [Related]
72. Cutaneous natural killer (NK) / T-cell lymphoma: nasal type with extensive facial destruction. Kost Al M; Kost Alová M; Belada D; Laco J Int J Dermatol; 2009 Dec; 48(12):1338-42. PubMed ID: 19930492 [No Abstract] [Full Text] [Related]
73. Clinicopathological categorization of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications. Paik JH; Choe JY; Kim H; Lee JO; Kang HJ; Shin HY; Lee DS; Heo DS; Kim CW; Cho KH; Kim TM; Jeon YK Leuk Lymphoma; 2017 Jan; 58(1):53-63. PubMed ID: 27157296 [TBL] [Abstract][Full Text] [Related]
74. Hydroa vacciniforme-like cutaneous T-cell lymphoma. Shi JQ; Chen QX; Li SF; Li W Indian J Dermatol; 2014 Jan; 59(1):91-3. PubMed ID: 24470671 [TBL] [Abstract][Full Text] [Related]
75. Epstein-Barr virus reactivation is induced, but abortive, in cutaneous lesions of systemic hydroa vacciniforme and hypersensitivity to mosquito bites. Yamamoto T; Hirai Y; Miyake T; Hamada T; Yamasaki O; Morizane S; Fujimoto W; Iwatsuki K J Dermatol Sci; 2016 Jun; 82(3):153-9. PubMed ID: 27039668 [TBL] [Abstract][Full Text] [Related]
76. Hydroa vacciniforme-like lymphoproliferative disorder in an elderly Chinese patient and a literature review of adult cases. Long V; Liang MW; Tan SH Int J Dermatol; 2018 Nov; 57(11):1283-1292. PubMed ID: 29926891 [TBL] [Abstract][Full Text] [Related]
77. Survival rates and prognostic factors of Epstein-Barr virus-associated hydroa vacciniforme and hypersensitivity to mosquito bites. Miyake T; Yamamoto T; Hirai Y; Otsuka M; Hamada T; Tsuji K; Morizane S; Suzuki D; Aoyama Y; Iwatsuki K Br J Dermatol; 2015 Jan; 172(1):56-63. PubMed ID: 25234411 [TBL] [Abstract][Full Text] [Related]
78. A report of Epstein-Barr virus-positive primary cutaneous natural killer-/T-cell lymphoma. Parker SR; Solomon AR; Lane JE J Am Acad Dermatol; 2008 Jul; 59(1):157-61. PubMed ID: 18468723 [TBL] [Abstract][Full Text] [Related]